Following the merger of Solexa and Lynx Therapeutics, Solexa CEO John West will become chief executive officer of the combined company, the partners announced. West joined Solexa last month from Applied Biosystems, where he was vice president of DNA platforms. He will also join the board of directors of the merged company, which will also include Craig Taylor, chairman of Lynx Therapeutics, and four venture capital members of the current Solexa board.
Joseph DeRisi and Vamsi Mootha are among the 23 new MacArthur fellows named by the MacArthur Foundation last week. Each fellow will receive $500,000 over the next five years. DeRisi, who has been developing microarrays, is an assistant professor of biochemistry and biophysics at the University of California, San Francisco. He is cited for “developing the means to measure thousands of genes simultaneously in an effort to decode the mysteries of cellular function.” Mootha is an assistant professor of systems biology at Harvard Medical School. He was recognized for “tapping into the wellspring of new data from molecular biology, genetics, and protein chemistry to identify the cause of, and possible treatment for, metabolic disease such as diabetes.”
Applied Biosystems has appointed Masahide Habu as president of ABI Japan. Habu will manage approximately 280 employees as the overseer of ABI’s Japanese operations. Prior to becoming president of ABI’s Japanese division, Habu was director of sales and marketing at ABI for one year. Before that, he was general manager of Kodak Professional’s Japan region, and vice president of health sciences for the Asia and Pacific Region at Kodak. Mark Stevenson, the former president and general manager of ABI Japan has been appointed division president of applied markets at ABI.